Publications

Assmus F, Adehin A, Hoglund R.M, Nyaulingo G, Mbarak H, Jongo S, Ackermann E, Reus E, Keiser J, Rocha Fbds, Specht S, Scandale I, Tarning J. Repurposing oxfendazole for onchocerciasis: population pharmacokinetics of a tablet formulation in healthy African adults. CPT Pharmacometrics Syst Pharmacol. 2026;15(2):e70189. DOI: 10.1002/psp4.70189

Jongo S, Ackermann E, Nyaulingo G, Mbaraka H, Reus E, Cicconi S, Saxena M, Kassim K, Tumbo A, Rashid M.A, Robinson S, Louis M, Satam V, Rocha Fbds, Scandale I, Assmus F, Keiser J, Specht S. Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers. Antimicrob Agents Chemother. 2026(in press):e0131525. DOI: 10.1128/aac.01315-25

Beynon F, Mhalu G, Kumar D, Cicconi S, Langet H, Levine G.A, Agarwal G, Festo C, Glass T.R, Jacob A, Kumar G, Lwambura S, Matata L, Mkopi A, Moshiro R, Schaer F, Bandi V, Bohle L.F, Emmanuel-Fabula M, Horlacher M, Horton S, Maiba J, Makawia S, Masanja N, Mjungu D, Mtebene I.E, Odek O, Oliveira V, Pantjushenko E, Reus E, Ruffo M, Sharma K, Storey H, Tyagi M, D'Acremont V, Masanja H, Awasthi S, Wyss K, TIMCI Collaborator Group. Effectiveness of introducing pulse oximetry and clinical decision support algorithms for the management of sick children in primary care in India and Tanzania on hospitalisation and mortality: the TIMCI pragmatic cluster randomised controlled trial. EClinicalMedicine. 2025;85:103306. DOI: 10.1016/j.eclinm.2025.103306

Langet H, Faye P.M, Njiri F, Cicconi S, Levine G.A, Glass T.R, Kosgei R.J, Ngari K, Schaer F, Thiongane A, Tine J.A.D, Ba M, Bohle L.F, Emmanuel-Fabula M, Faye M.M, Horton S, Miheso A, Mugo M, Ngutu M, Ruffo M, Shauri J, Sougou N.M, D’Acremont V, Wyss K, Ndiaye O, Beynon F, The TIMCI Collaborator Group. Effectiveness of introducing pulse oximetry and clinical decision support algorithms for the management of sick children in primary care in Kenya and Senegal on referral and antibiotic prescription: the TIMCI quasi-experimental pre-post study. eClinicalMedicine. 2025;83:103196. DOI: 10.1016/j.eclinm.2025.103196

Beynon F, Langet H, Bohle L.F, Awasthi S, Ndiaye O, Machoki M'Imunya J, Masanja H, Horton S, Ba M, Cicconi S, Emmanuel-Fabula M, Faye P.M, Glass T.R, Keitel K, Kumar D, Kumar G, Levine G.A, Matata L, Mhalu G, Miheso A, Mjungu D, Njiri F, Reus E, Ruffo M, Schär F, Sharma K, Storey H.L, Masanja I, Wyss K, D'Acremont V, TIMCI Collaborator Group. The Tools for Integrated Management of Childhood Illness (TIMCI) study protocol: a multi-country mixed-method evaluation of pulse oximetry and clinical decision support algorithms. Glob Health Action. 2024;17:2326253. DOI: 10.1080/16549716.2024.2326253

Chernet A, Paris D.H, Alchalabi L, Utzinger J, Reus E. Public and patient involvement in migration health research: Eritrean and Syrian refugees' and asylum seekers' views in Switzerland. Healthcare (Basel). 2024;12(16):1654. DOI: 10.3390/healthcare12161654

Nébié E.I, van Eeuwijk P, Sawadogo H.N, Reus E, Utzinger J, Burri C. Operational differences between product development partnership, pharmaceutical industry, and investigator initiated clinical trials. Trop Med Infect Dis. 2024;9(3):56. DOI: 10.3390/tropicalmed9030056

Mäser P, Bernhard S, Brun R, Burri C, Gagneux S, Hetzel M.W, Kaiser M, Lengeler C, Pluschke G, Reus E, Rottmann M, Utzinger J, Warryn L, Wittlin S, Keiser J. Key contributions by the Swiss Tropical and Public Health Institute towards new and better drugs for tropical diseases. Chimia (Aarau). 2023;77(9):593-606. DOI: 10.2533/chimia.2023.593

Nébié E.I, Sawadogo H.N, van Eeuwijk P, Signorell A, Reus E, Utzinger J, Burri C. Opportunities and challenges for decentralised clinical trials in sub-Saharan Africa: a qualitative study. BMJ Open. 2023;13(9):e075903. DOI: 10.1136/bmjopen-2023-075903